These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 12461788)

  • 1. Induction of p202, a modulator of apoptosis, during oncogenic transformation of NIH 3T3 cells by activated H-Ras (Q61L) contributes to cell survival.
    Xin H; Geng Y; Pramanik R; Choubey D
    J Cell Biochem; 2003 Jan; 88(1):191-204. PubMed ID: 12461788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p202 levels are negatively regulated by serum growth factors.
    Geng Y; D'Souza S; Xin H; Walter S; Choubey D
    Cell Growth Differ; 2000 Sep; 11(9):475-83. PubMed ID: 11007452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The downregulation of the pro-apoptotic protein Par-4 is critical for Ras-induced survival and tumor progression.
    Barradas M; Monjas A; Diaz-Meco MT; Serrano M; Moscat J
    EMBO J; 1999 Nov; 18(22):6362-9. PubMed ID: 10562548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells.
    Cheng G; Meinkoth JL
    Oncogene; 2001 Nov; 20(50):7334-41. PubMed ID: 11704863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts.
    Cuadrado A; Bruder JT; Heidaran MA; App H; Rapp UR; Aaronson SA
    Oncogene; 1993 Sep; 8(9):2443-8. PubMed ID: 8361757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoblastoma (Rb) protein upregulates expression of the Ifi202 gene encoding an interferon-inducible negative regulator of cell growth.
    Xin H; Pramanik R; Choubey D
    Oncogene; 2003 Jul; 22(31):4775-85. PubMed ID: 12894219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Ras-induced oncogenic transformation of NIH-3T3 cells using differential-display 2-DE proteomics.
    Ji H; Moritz RL; Kim YS; Zhu HJ; Simpson RJ
    Electrophoresis; 2007 Jun; 28(12):1997-2008. PubMed ID: 17526045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line.
    Himelstein BP; Lee EJ; Sato H; Seiki M; Muschel RJ
    Oncogene; 1997 Apr; 14(16):1995-8. PubMed ID: 9150367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of the mouse Necl-5/Tage4/PVR/CD155 gene by fibroblast growth factor or oncogenic Ras through the Raf-MEK-ERK-AP-1 pathway.
    Hirota T; Irie K; Okamoto R; Ikeda W; Takai Y
    Oncogene; 2005 Mar; 24(13):2229-35. PubMed ID: 15688018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective activation of Ha-ras(val12) oncogene increases susceptibilityof NIH/3T3 cells to TNF-alpha.
    Chang MY; Won SJ; Yang BC; Jan MS; Liu HS
    Exp Cell Res; 1999 May; 248(2):589-98. PubMed ID: 10222151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma regulation of the human mimecan promoter.
    Tasheva ES; Conrad GW
    Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenic Ras, but not (V600E)B-RAF, protects from cholesterol depletion-induced apoptosis through the PI3K/AKT pathway in colorectal cancer cells.
    Calleros L; Sánchez-Hernández I; Baquero P; Toro MJ; Chiloeches A
    Carcinogenesis; 2009 Oct; 30(10):1670-7. PubMed ID: 19700418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oncogenic and transcriptional cooperation with Ha-Ras requires phosphorylation of c-Jun on serines 63 and 73.
    Smeal T; Binetruy B; Mercola DA; Birrer M; Karin M
    Nature; 1991 Dec; 354(6353):494-6. PubMed ID: 1749429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dominant-negative Rac1 suppresses Ras-induced apoptosis possibly through activation of NFkappaB in Ha-ras oncogene-transformed NIH/3T3 cells.
    Chou CK; Liang KH; Tzeng CC; Huang GC; Chuang JI; Chang TY; Liu HS
    Life Sci; 2006 Mar; 78(16):1823-9. PubMed ID: 16274703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of apicidin, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Im JY; Kim J; Choi WS; Kim HS
    Int J Mol Med; 2008 Mar; 21(3):325-33. PubMed ID: 18288380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic H-Ras up-regulates expression of ERCC1 to protect cells from platinum-based anticancer agents.
    Youn CK; Kim MH; Cho HJ; Kim HB; Chang IY; Chung MH; You HJ
    Cancer Res; 2004 Jul; 64(14):4849-57. PubMed ID: 15256455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.
    Zhu Y; Denhardt DT; Cao H; Sutphin PD; Koong AC; Giaccia AJ; Le QT
    Oncogene; 2005 Sep; 24(43):6555-63. PubMed ID: 16007184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interferon-inducible growth-inhibitory p202 protein: DNA binding properties and identification of a DNA binding domain.
    Choubey D; Gutterman JU
    Biochem Biophys Res Commun; 1996 Apr; 221(2):396-401. PubMed ID: 8619867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Fas (CD95) expression and Fas-mediated apoptosis by oncogenic Ras.
    Fenton RG; Hixon JA; Wright PW; Brooks AD; Sayers TJ
    Cancer Res; 1998 Aug; 58(15):3391-400. PubMed ID: 9699671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.